Ductal Carcinoma In Situ Clinical Trial
Official title:
TBCRC 042 - A Randomized Phase II Window-of-Opportunity Trial of Ruxolitinib in Patients With High Risk and Premalignant Breast Conditions
This study is evaluating how ruxolitinib affects premalignant breast cells. One half of the study participants will receive ruxolitinib for approximately 15 days, and the other half will receive a placebo (sugar pill) for approximately 15 days. Once study participants have completed their ruxolitinib or placebo, participants will undergo surgery to remove the premalignant breast tissue.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT02889458 -
Hong Kong Breast Cancer Study
|
||
Completed |
NCT00757302 -
Intraoperative Gamma Camera for Breast Cancer Surgery
|
Phase 3 | |
Active, not recruiting |
NCT03216421 -
Intraoperative Radiation Therapy (IORT) in DCIS
|
N/A | |
Completed |
NCT03775213 -
Acceptability of Active Monitoring (AM) as a Treatment Option for Ductal Carcinoma in Situ (DCIS)
|
N/A | |
Active, not recruiting |
NCT00605982 -
Breast MRI as a Preoperative Tool for DCIS
|
N/A | |
Enrolling by invitation |
NCT04365114 -
Patient Outcomes From Second Film-readers and Test Threshold Relaxation in Breast Screening
|
||
Completed |
NCT04248179 -
The Ultrasound-guided Multiple-injection Costotransverse Block for Mastectomy and Primary Reconstructive Surgery.
|
Phase 4 | |
Withdrawn |
NCT05032079 -
Subzero and Scorpion Trial
|
N/A | |
Recruiting |
NCT05218044 -
Cryoablation as a Minimally Invasive Alternative to Surgery for Managing Ductal Carcinoma In Situ
|
N/A | |
Active, not recruiting |
NCT01644669 -
Safety and Efficacy Study of the Xoft® Axxent® eBx® IORT System®
|
N/A | |
Recruiting |
NCT06133647 -
Demographics, Characteristics and Outcomes of Male Breast Cancer Patients at Methodist Health System
|
||
Completed |
NCT01815476 -
The Prone Breast Radiation Therapy Trial
|
N/A | |
Not yet recruiting |
NCT06033092 -
Low Dose TamOxifen and LifestylE Changes for bReast cANcer prevenTion
|
Phase 2 | |
Terminated |
NCT02137252 -
Naltrexone RCT for Treatment-Emergent Fatigue in Patients Receiving Radiation Therapy for Breast Cancer
|
Phase 2 | |
Terminated |
NCT01060345 -
A Pilot Study of Chemo-prevention of Green Tea in Women With Ductal Carcinoma in Situ
|
Phase 2 | |
Recruiting |
NCT00669747 -
Study Of Intraductal Carboplatin In Women With Ductal Carcinoma In Situ (DCIS)
|
Phase 2 | |
Completed |
NCT00742222 -
Electronic Xoft Intersociety Brachytherapy Trial: Electronic Brachytherapy (EBT) For Treatment of Early Stage Breast Cancer
|
Phase 4 | |
Active, not recruiting |
NCT02909426 -
The Mammography and Ultrasonography STudy for Breast Cancer Screening Effectiveness
|
||
Completed |
NCT03375892 -
The Use of Deep Inspiration Breath Hold and Prone Irradiation to Decrease Cardiac Radiation Exposure
|
N/A | |
Withdrawn |
NCT03437915 -
BrUOG 351: PRE-OPERATIVE APBI USING NIBB
|
N/A |